Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Burtness

Showing results (11-20 of 184) with videos related to

Pageof 19
Sort By:
Cancer Journal (Sudbury, Mass.)|September 27, 2022
Integrating Targeted Therapies in the Management of Head and Neck CancersBarbara Burtness
Cancers of the Head & Neck|May 17, 2019
Introducing cancers of the head and neck, a new open access journalBarbara Burtness
Nature Reviews. Clinical Oncology|October 29, 2010
Targeted therapies: Molecular selection for 'smart' study design in lung cancerAmanda Psyrri, Barbara Burtness
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2015
Human Papillomavirus-Associated Oropharyngeal Cancer: Defining Risk Groups and Clinical TrialsAarti Bhatia, Barbara Burtness
International Journal of Radiation Oncology, Biology, Physics|July 20, 2017
Immune Checkpoint Inhibition in Cancers that Affect the Head and NeckJanaki Parameswaran, Barbara Burtness
Oral Oncology|October 9, 2020
Reply to "Keynote 48: Is it really for everyone?"Barbara Burtness, Joy Ge
Drugs of Today (Barcelona, Spain : 1998)|April 12, 2005
Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibodyJoanne Harding, Barbara Burtness
Expert Review of Anticancer Therapy|September 2, 2008
Viruses in head and neck cancers: prevention and therapyAmanda Psyrri, Barbara Burtness
Drugs|January 16, 2023
Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 UpdateAarti Bhatia, Barbara Burtness
Cancer|January 24, 2023
Top advances of the year: Head and neck cancerAvanti Verma, Barbara Burtness
Pageof 19

Showing results (11-20 of 184) with videos related to

Sort By:
Pageof 19
Cancer Journal (Sudbury, Mass.)|September 27, 2022
Integrating Targeted Therapies in the Management of Head and Neck CancersBarbara Burtness
Cancers of the Head & Neck|May 17, 2019
Introducing cancers of the head and neck, a new open access journalBarbara Burtness
Nature Reviews. Clinical Oncology|October 29, 2010
Targeted therapies: Molecular selection for 'smart' study design in lung cancerAmanda Psyrri, Barbara Burtness
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2015
Human Papillomavirus-Associated Oropharyngeal Cancer: Defining Risk Groups and Clinical TrialsAarti Bhatia, Barbara Burtness
International Journal of Radiation Oncology, Biology, Physics|July 20, 2017
Immune Checkpoint Inhibition in Cancers that Affect the Head and NeckJanaki Parameswaran, Barbara Burtness
Oral Oncology|October 9, 2020
Reply to "Keynote 48: Is it really for everyone?"Barbara Burtness, Joy Ge
Drugs of Today (Barcelona, Spain : 1998)|April 12, 2005
Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibodyJoanne Harding, Barbara Burtness
Expert Review of Anticancer Therapy|September 2, 2008
Viruses in head and neck cancers: prevention and therapyAmanda Psyrri, Barbara Burtness
Drugs|January 16, 2023
Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 UpdateAarti Bhatia, Barbara Burtness
Cancer|January 24, 2023
Top advances of the year: Head and neck cancerAvanti Verma, Barbara Burtness
Pageof 19